A new synthetic molecule switches between emitting green and blue light after application of a solvent or mild heat. The color-changing phosphor can be leveraged for a two-layered information encoding ...

SOUTH SAN FRANCISCO, Calif., March 25, 2026--(BUSINESS WIRE)--Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe ...

FDA alignment achieved on pivotal study design supporting a planned Biologics License Application (BLA) submission 30-patient pivotal study initiated, evaluating seizure reduction and ...

I never thought smart home tech was for me. Maybe that’s because my introduction to it was largely centered around my friends incessantly yelling “Hey Google!” whenever they wanted a light turned on ...

For almost a century, psychologists and neuroscientists have been trying to understand how humans memorize different types of information, ranging from knowledge or facts to the recollection of ...

In a new study, published in Cell, researchers describe a newfound mechanism for creating proteins in a giant DNA virus, comparable to a mechanism in eukaryotic cells. The finding challenges the dogma ...

– Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing ...

Curious how the Caesar Cipher works? This Python tutorial breaks it down in a simple, beginner-friendly way. Learn how to encode and decode messages using one of the oldest and most famous encryption ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced positive ...